|
Oxaliplatin Kabi 5 mg/ml con inf 1x20 ml/100 mg (liek.inj.skl.)
5 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01XA03
|
Fresenius Kabi s.r.o. |
—
|
|
Oxaliplatin Kabi 5 mg/ml con inf 1x40 ml/200 mg (liek.inj.skl.)
5 mg/1 ml
|
Koncentrát na infúzny roztok (Infúzny koncentrát - platné do okt2020) |
L01XA03
|
Fresenius Kabi s.r.o. |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 10x100 mg+20 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 10x50 mg+10 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 1x100 mg+20 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 1x50 mg+10 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 2x100 mg+20 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 2x50 mg+10 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 3x100 mg+20 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 3x50 mg+10 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 50x100 mg+20 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 50x50 mg+10 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 5x100 mg+20 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Oxaliplatina Viatris 5 mg/ml plv ifo 5x50 mg+10 ml solv.
5 mg/1 ml
|
Prášok na infúzny roztok |
L01XA03
|
Viatris Limited |
—
|
|
Metvix crm der 1x1 g (tuba Al)
160 mg/1 g
|
Dermálny krém |
L01XD03
|
GALDERMA INTERNATIONAL |
—
|
|
Metvix crm der 1x2 g (tuba Al)
160 mg/1 g
|
Dermálny krém |
L01XD03
|
GALDERMA INTERNATIONAL |
—
|
|
Vesanoid 10 mg cps mol 100x10 mg (liek.skl.hnedá)
10 mg
|
Mäkká kapsula |
L01XF01
|
CHEPLAPHARM Arzneimittel GmbH |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 100x500 mg (blis.Al/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 100x500 mg (blis.PVC/Aclar/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 30x500 mg (blis.Al/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 30x500 mg (blis.PVC/Aclar/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 50x500 mg (blis.Al/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
XYBAID 500 mg tvrdé kapsuly cps dur 50x500 mg (blis.PVC/Aclar/Al)
500 mg
|
Tvrdá kapsula |
L01XX05
|
MAKPHARM d.o.o. |
—
|
|
MEGESIN 160 mg tbl 100x160 mg
160 mg
|
Tableta |
L02AB01
|
Teva B.V. |
—
|